BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35998681)

  • 1. Association Between Retinopathy of Prematurity in Very-Low-Birth-Weight Infants and Neurodevelopmental Impairment.
    Han G; Lim DH; Kang D; Cho J; Guallar E; Chang YS; Chung TY; Kim SJ; Park WS
    Am J Ophthalmol; 2022 Dec; 244():205-215. PubMed ID: 35998681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental Outcomes in Infants Screened for Retinopathy of Prematurity.
    Karmouta R; Strawbridge JC; Langston S; Altendahl M; Khitri M; Chu A; Tsui I
    JAMA Ophthalmol; 2023 Dec; 141(12):1125-1132. PubMed ID: 37883103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental outcomes in very low birthweight infants with retinopathy of prematurity in a nationwide cohort study.
    Ahn JH; Lee KM; Kim MJ; Park HK; Kim YJ; Ahn SJ; Lee HJ
    Sci Rep; 2022 Mar; 12(1):5053. PubMed ID: 35322163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopmental Outcomes after Bevacizumab Treatment for Retinopathy of Prematurity: A Meta-analysis.
    Tsai CY; Yeh PT; Tsao PN; Chung YE; Chang YS; Lai TT
    Ophthalmology; 2021 Jun; 128(6):877-888. PubMed ID: 33212122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental Outcomes for Retinopathy of Prematurity: A Taiwan Premature Infant Follow-up Network Database Study.
    Chiang MC; Chen YT; Kang EY; Chen KJ; Wang NK; Liu L; Chen YP; Hwang YS; Lai CC; Wu WC
    Am J Ophthalmol; 2023 Mar; 247():170-180. PubMed ID: 36343698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy of prematurity and neurodevelopmental outcomes in preterm infants: A systematic review and meta-analysis.
    Diggikar S; Gurumoorthy P; Trif P; Mudura D; Nagesh NK; Galis R; Vinekar A; Kramer BW
    Front Pediatr; 2023; 11():1055813. PubMed ID: 37009271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab and neurodevelopmental outcomes of preterm infants with retinopathy of prematurity: should we still worry?
    Celik P; Ayranci Sucakli I; Kara C; Petricli IS; Kavurt S; Celik IH; Bas AY; Demirel N
    J Matern Fetal Neonatal Med; 2022 Feb; 35(3):415-422. PubMed ID: 33618591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment.
    Natarajan G; Shankaran S; Nolen TL; Sridhar A; Kennedy KA; Hintz SR; Phelps DL; DeMauro SB; Carlo WA; Gantz MG; Das A; Greenberg RG; Younge NE; Bliss JM; Seabrook R; Sánchez PJ; Wyckoff MH; Bell EF; Vohr BR; Higgins RD
    Pediatrics; 2019 Aug; 144(2):. PubMed ID: 31337693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorer neurodevelopmental outcomes associated with cystoid macular edema identified in preterm infants in the intensive care nursery.
    Rothman AL; Tran-Viet D; Gustafson KE; Goldstein RF; Maguire MG; Tai V; Sarin N; Tong AY; Huang J; Kupper L; Cotten CM; Freedman SF; Toth CA
    Ophthalmology; 2015 Mar; 122(3):610-9. PubMed ID: 25439600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units.
    Bas AY; Demirel N; Koc E; Ulubas Isik D; Hirfanoglu İM; Tunc T;
    Br J Ophthalmol; 2018 Dec; 102(12):1711-1716. PubMed ID: 29519879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinopathy of Prematurity among Very-Low-Birth-Weight Infants in Korea: Incidence, Treatment, and Risk Factors.
    Hwang JH; Lee EH; Kim EA
    J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S88-94. PubMed ID: 26566363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External Validation of a Retinopathy of Prematurity Screening Model Using Artificial Intelligence in 3 Low- and Middle-Income Populations.
    Coyner AS; Oh MA; Shah PK; Singh P; Ostmo S; Valikodath NG; Cole E; Al-Khaled T; Bajimaya S; K C S; Chuluunbat T; Munkhuu B; Subramanian P; Venkatapathy N; Jonas KE; Hallak JA; Chan RVP; Chiang MF; Kalpathy-Cramer J; Campbell JP
    JAMA Ophthalmol; 2022 Aug; 140(8):791-798. PubMed ID: 35797036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is thrombocytopenia and postnatal weight gain associated with treatment-requiring retinopathy of prematurity? A matched case-control study.
    Seliniotaki AK; Lithoxopoulou M; Moutzouri S; Bouras E; Diamanti E; Ziakas N; Lundgren P; Hellström A; Haidich AB; Mataftsi A
    Acta Ophthalmol; 2023 Jun; 101(4):433-442. PubMed ID: 36468823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Chandra P
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore.
    Shah VA; Yeo CL; Ling YL; Ho LY
    Ann Acad Med Singap; 2005 Mar; 34(2):169-78. PubMed ID: 15827664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study.
    Ying GS; VanderVeen D; Daniel E; Quinn GE; Baumritter A;
    Ophthalmology; 2016 Oct; 123(10):2176-82. PubMed ID: 27491396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
    Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of retinopathy of prematurity in very-low-birth-weight infants born at Kalafong Hospital, Pretoria.
    Delport SD; Swanepoel JC; Odendaal PJ; Roux P
    S Afr Med J; 2002 Dec; 92(12):986-90. PubMed ID: 12561416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity.
    Morin J; Luu TM; Superstein R; Ospina LH; Lefebvre F; Simard MN; Shah V; Shah PS; Kelly EN;
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 27244705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Msall ME; Phelps DL; DiGaudio KM; Dobson V; Tung B; McClead RE; Quinn GE; Reynolds JD; Hardy RJ; Palmer EA
    Pediatrics; 2000 Nov; 106(5):998-1005. PubMed ID: 11061766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.